Interaction of significantly changed genes and their linked pathways. by Mohamad Ammar Ayass (13775290)

Pre and post-treatment mean EPG values on days 0, 7, 14, 21, and 28. by Sohail Afzal (10850709)

Subjects:

Changes in clinical variables. by Karel Joineau (21799908)

Subjects:

Fig 8 - by Harshita Sharma (4836180)

Subjects:

Boxplots with mean median and first and third quartiles visualizing changes in all CMJ and DJ metrics across the three time-points, broken down by RSA classification. by Nicolas M. Philipp (13272198)

Subjects:

CNP lowered GAPDH activity in melanoma cells. by Claudia von Montfort (256730)

Subjects:

Supporting information – data for plots. by Maria Nadinskaia (22662419)

Subjects:

Tissue-specific profiling of the photoreceptor nuclear transcriptome reveals significant changes in early and late aging. by Juan Jauregui-Lozano (12024868)

Changes in growth characteristics (A = shoot length; B = root length; C = collar diameter; D = number of leaves) of M. stenopetala under drought conditions. by Nadia Khater (22553166)

Subjects:

FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma. by Laura L. Stafman (6577184)

“…There was a trend toward decreased Ki67 staining in FTY720-treated tumors (p = 0.29). …”

Conditional <i>Aff4</i> knockout decreases fat mass in mice. by Yaqian Chen (1711576)

Mutations in the flexible residue, Arg358, decrease sensitivity to bile acid germinant. by Amy E. Rohlfing (6919355)

Vitamin C decreases the obesogenic and hyperglycemic effect of invert sugar in prediabetic rats by Patrícia MOLZ (6744857)

“…Conclusion: Vitamin C has anti-obesogenic and glycemia-lowering effects in Wistar rats, which might be promising to prediabetics. …”

County-level geographical septile distribution for the first 12 statistically significant factors with at least one statistically significant coefficient ranked by decreasing ΔIC. by Yanan Long (11784717)

Meta-regression of mean macroscopic adhesion score by a dose of methylene blue. by Su Hyun Seo (12568512)

Subjects:

Presentation_1_Longitudinal High-Throughput Sequencing of the T-Cell Receptor Repertoire Reveals Dynamic Change and Prognostic Significance of Peripheral Blood TCR Diversity in Metastatic Colorectal Cancer During Chemotherapy.pdf by Yi-Tung Chen (6743102)

“…The diversity of TCR repertoires and CDR3 clonotypes decreased in most mCRC patients after therapy. Furthermore, compared with baseline TCR diversity, patients whose TCR diversity dropped considerably during therapy had better treatment responses, including lower CEA and CA19-9 levels and smaller tumor sizes. …”

Table_2_Longitudinal High-Throughput Sequencing of the T-Cell Receptor Repertoire Reveals Dynamic Change and Prognostic Significance of Peripheral Blood TCR Diversity in Metastatic Colorectal Cancer During Chemotherapy.xlsx by Yi-Tung Chen (6743102)

“…The diversity of TCR repertoires and CDR3 clonotypes decreased in most mCRC patients after therapy. Furthermore, compared with baseline TCR diversity, patients whose TCR diversity dropped considerably during therapy had better treatment responses, including lower CEA and CA19-9 levels and smaller tumor sizes. …”

Table_4_Longitudinal High-Throughput Sequencing of the T-Cell Receptor Repertoire Reveals Dynamic Change and Prognostic Significance of Peripheral Blood TCR Diversity in Metastatic Colorectal Cancer During Chemotherapy.xlsx by Yi-Tung Chen (6743102)

“…The diversity of TCR repertoires and CDR3 clonotypes decreased in most mCRC patients after therapy. Furthermore, compared with baseline TCR diversity, patients whose TCR diversity dropped considerably during therapy had better treatment responses, including lower CEA and CA19-9 levels and smaller tumor sizes. …”

Table_1_Longitudinal High-Throughput Sequencing of the T-Cell Receptor Repertoire Reveals Dynamic Change and Prognostic Significance of Peripheral Blood TCR Diversity in Metastatic Colorectal Cancer During Chemotherapy.xlsx by Yi-Tung Chen (6743102)

“…The diversity of TCR repertoires and CDR3 clonotypes decreased in most mCRC patients after therapy. Furthermore, compared with baseline TCR diversity, patients whose TCR diversity dropped considerably during therapy had better treatment responses, including lower CEA and CA19-9 levels and smaller tumor sizes. …”

Table_5_Longitudinal High-Throughput Sequencing of the T-Cell Receptor Repertoire Reveals Dynamic Change and Prognostic Significance of Peripheral Blood TCR Diversity in Metastatic Colorectal Cancer During Chemotherapy.xlsx by Yi-Tung Chen (6743102)

“…The diversity of TCR repertoires and CDR3 clonotypes decreased in most mCRC patients after therapy. Furthermore, compared with baseline TCR diversity, patients whose TCR diversity dropped considerably during therapy had better treatment responses, including lower CEA and CA19-9 levels and smaller tumor sizes. …”